Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3023)
All Articles published online
|
May 7, 2005 (publication date) through May 3, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li MS, Ma QL, Chen Q, Liu XH, Li PF, Du GG, Li G. Alpha-fetoprotein triggers hepatoma cells escaping from immune surveillance through altering the expression of Fas/FasL and tumor necrosis factor related apoptosis-inducing ligand and its receptor of lymphocytes and liver cancer cells. World J Gastroenterol 2005; 11(17): 2564-2569 [PMID: 15849812 DOI: 10.3748/wjg.v11.i17.2564] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i17/2564.htm |
| Number | Citing Articles |
| 1 |
Duan Xie, Dongxia Li, Fangrong Hu, Zhiyou Wang, Longhui Zhang, Mingzhu Jiang, Yuanli Wang. Terahertz Metamaterial Biosensor With Double Resonant Frequencies for Specific Detection of Early-Stage Hepatocellular Carcinoma. IEEE Sensors Journal 2023; 23(2): 1124 doi: 10.1109/JSEN.2022.3225344
|
| 2 |
Jia Xu, Chang Liu, Lei Zhou, Feng Tian, Ming-Hui Tai, Ji-Chao Wei, Kai Qu, Fan-Di Meng, Ling-Qiang Zhang, Zhi-Xin Wang, Jing-Yao Zhang, Hu-Lin Chang, Si-Nan Liu, Xin-Shen Xu, Yan-Zhou Song, Jun Liu, Peng Zhang. Distinctions Between Clinicopathological Factors and Prognosis of Alpha-fetoprotein Negative and Positive Hepatocelluar Carcinoma Patients. Asian Pacific Journal of Cancer Prevention 2012; 13(2): 559 doi: 10.7314/APJCP.2012.13.2.559
|
| 3 |
Chao He, Wei Peng, Xiaojuan Liu, Chuan Li, Xueting Li, Tian-Fu Wen. Post-treatment alpha-fetoprotein response predicts prognosis of patients with hepatocellular carcinoma. Medicine 2019; 98(31): e16557 doi: 10.1097/MD.0000000000016557
|
| 4 |
Zijing Liu, Youwei Pu, Yixi Bao, Song He. Investigation of Potential Molecular Biomarkers for Diagnosis and Prognosis of AFP-Negative HCC. International Journal of General Medicine 2021; : 4369 doi: 10.2147/IJGM.S323868
|
| 5 |
Tianke Chen, Xiaowei Dai, Juji Dai, Chaodong Ding, Zheng Zhang, Ziqi Lin, Jin Hu, Mei Lu, Zhanyu Wang, Yalei Qi, Li Zhang, Rulu Pan, Zhu Zhao, Liting Lu, Wanqin Liao, Xincheng Lu. AFP promotes HCC progression by suppressing the HuR-mediated Fas/FADD apoptotic pathway. Cell Death & Disease 2020; 11(10) doi: 10.1038/s41419-020-03030-7
|
| 6 |
Shelli M. Morris, Ji Yeon Baek, Amanda Koszarek, Samornmas Kanngurn, Sue E. Knoblaugh, William M. Grady. Transforming growth factor-beta signaling promotes hepatocarcinogenesis induced by p53 loss. Hepatology 2012; 55(1): 121 doi: 10.1002/hep.24653
|
| 7 |
Giulia Morsica, Laura Galli, Emanuela Messina, Alessandro Cibarelli, Sabrina Bagaglio, Andrea Poli, Martina Ranzenigo, Antonella Castagna, Hamid Hasson, Caterina Uberti-Foppa, Alessandro Granito. Levels of Alpha-Fetoprotein and Association with Mortality in Hepatocellular Carcinoma of HIV-1-Infected Patients. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/3586064
|
| 8 |
Mingyue Zhu, Wei Li, Yan Lu, Xu Dong, Yi Chen, Bo Lin, Xieju Xie, Junli Guo, Mengsen Li. Alpha fetoprotein antagonizes apoptosis induced by paclitaxel in hepatoma cells in vitro. Scientific Reports 2016; 6(1) doi: 10.1038/srep26472
|
| 9 |
Wei Wu, Dengfu Yao, Liwei Qiu, Xiaoxiao Gu, Xinhua Wu. Quantitative analysis of hepatoma-specific α-fetoprotein (HS-AFP) by a new mini-column affinity chromatography and its clinical value in diagnosis of hepatocellular carcinoma. The Chinese-German Journal of Clinical Oncology 2008; 7(3): 131 doi: 10.1007/s10330-007-0167-4
|
| 10 |
Bin Xiao, Xiao Li, Xiu-Yun Feng, Shuai Gong, Zhi-Bin Li, Jie Zhang, Hong-Jie Yuan, Jing-He Tan. Restraint stress of male mice induces apoptosis in spermatozoa and spermatogenic cells: role of the FasL/Fas system†. Biology of Reproduction 2019; 101(1): 235 doi: 10.1093/biolre/ioz057
|
| 11 |
Hua Tang, Xiao-Yan Tang, Min Liu, Xin Li. Targeting alpha-fetoprotein represses the proliferation of hepatoma cells via regulation of the cell cycle. Clinica Chimica Acta 2008; 394(1-2): 81 doi: 10.1016/j.cca.2008.04.012
|
| 12 |
Chao Zhang, Hui Li, Wei Jiang, Xiaowei Zhang, Gang Li. Icaritin inhibits the expression of alpha-fetoprotein in hepatitis B virus-infected hepatoma cell lines through post-transcriptional regulation. Oncotarget 2016; 7(50): 83755 doi: 10.18632/oncotarget.13194
|
| 13 |
Lin Zhou, Jia Liu, Feng Luo. Serum tumor markers for detection of hepatocellular carcinoma. World Journal of Gastroenterology 2006; 12(8): 1175-1181 doi: 10.3748/wjg.v12.i8.1175
|
| 14 |
So Tsuboi, Kazuhisa Taketa, Kazuhiro Nouso, Tatsuya Fujikawa, Koji Manabe, Hiroyuki Ohmori, Toshihiro Higashi, Yasushi Shiratori. High Level of Expression of α-Fetoprotein Receptor in Gastric Cancers. Tumor Biology 2006; 27(6): 283 doi: 10.1159/000096071
|
| 15 |
Pablo Matar, Laura Alaniz, Viviana Rozados, Jorge B Aquino, Mariana Malvicini, Catalina Atorrasagasti, Manuel Gidekel, Marcelo Silva, O Graciela Scharovsky, Guillermo Mazzolini. Immunotherapy for liver tumors: present status and future prospects. Journal of Biomedical Science 2009; 16(1) doi: 10.1186/1423-0127-16-30
|
| 16 |
Yasushi Tamura, Satoshi Yamagiwa, Yohei Aoki, So Kurita, Takeshi Suda, Shogo Ohkoshi, Minoru Nomoto, Yutaka Aoyagi. Serum Alpha-Fetoprotein Levels During and After Interferon Therapy and the Development of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C. Digestive Diseases and Sciences 2009; 54(11): 2530 doi: 10.1007/s10620-008-0642-y
|
| 17 |
Bin Xu, Minpeng Li, Yuan Yu, Jun He, Siqin Hu, Meng Pan, Shifeng Lu, Ke Liao, Zhuang Pan, Yanxun Zhou, Jiye Zhu. Effects of harmaline on cell growth of human liver cancer through the p53/p21 and Fas/FasL signaling pathways. Oncology Letters 2017; doi: 10.3892/ol.2017.7495
|
| 18 |
WEY-RAN LIN, CHAO-WEI HSU, YI-CHENG CHEN, MING-LING CHANG, KUNG-HAO LIANG, YA-HUI HUANG, CHAU-TING YEH. GALNT14 genotype, α-fetoprotein and therapeutic side effects predict post-chemotherapy survival in patients with advanced hepatocellular carcinoma. Molecular and Clinical Oncology 2014; 2(4): 630 doi: 10.3892/mco.2014.294
|
| 19 |
Yong-Qiang Weng, Shuang-Jian Qiu, Yin-Kun Liu, Jia Fan, Qiang Gao, Zhao-You Tang. Down-regulation of β-centractin might be involved in dendritic cells dysfunction and subsequent hepatocellular carcinoma immune escape: a proteomic study. Journal of Cancer Research and Clinical Oncology 2007; 134(2): 179 doi: 10.1007/s00432-007-0267-0
|
| 20 |
Chao He, Xiaoyun Zhang, Chuan Li, Wei Peng, Tian-Fu Wen, Lv-Nan Yan, Jiayin Yang, Wusheng Lu. Changes of alpha-fetoprotein levels could predict recurrent hepatocellular carcinoma survival after trans-arterial chemoembolization. Oncotarget 2017; 8(49): 85599 doi: 10.18632/oncotarget.20343
|
| 21 |
Junwei Chen, Lisha Lai, Qu Lin, Wensou Huang, Mingyue Cai, Kangshun Zhu, Mingsheng Huang. Hepatic resection after transarterial chemoembolization increases overall survival in large/multifocal hepatocellular carcinoma: a retrospective cohort study. Oncotarget 2017; 8(1): 408 doi: 10.18632/oncotarget.13427
|
| 22 |
Chao Zhang, Peng Liu, Chuanbao Zhang. Hepatitis B Virus X Protein Up-Regulates Alpha-Fetoprotein to Promote Hepatocellular Carcinoma by Targeting miR-1236 and miR-1270. SSRN Electronic Journal 2019; doi: 10.2139/ssrn.3356837
|
| 23 |
G. J. Mizejewski. Nonsecreted cytoplasmic alpha-fetoprotein: a newly discovered role in intracellular signaling and regulation. An update and commentary. Tumor Biology 2015; 36(12): 9857 doi: 10.1007/s13277-015-3736-0
|
| 24 |
A. V. Morozov, V. A. Morozov, T. M. Astakhova, A. V. Timofeev, V. L. Karpov. DNA vaccine encoding α-fetoprotein fused with the ornithine decarboxylase degradation signal significantly suppresses the hepatocellular carcinoma growth in mice. Molecular Biology 2012; 46(3): 391 doi: 10.1134/S0026893312030089
|
| 25 |
Wei-ying Zhang, Na Cai, Li-hong Ye, Xiao-dong Zhang. Transformation of human liver L-O2 cells mediated by stable HBx transfection. Acta Pharmacologica Sinica 2009; 30(8): 1153 doi: 10.1038/aps.2009.99
|
| 26 |
Xiaojun Yang, Youcheng Zhang, Lingyi Zhang, Lin Zhang, Jie Mao. Silencing alpha-fetoprotein expression induces growth arrest and apoptosis in human hepatocellular cancer cell. Cancer Letters 2008; 271(2): 281 doi: 10.1016/j.canlet.2008.06.017
|
| 27 |
Xiaohong Chen, Boheng Zhang, Xin Yin, Zhenggang Ren, Shuangjian Qiu, Jian Zhou. Lipiodolized transarterial chemoembolization in hepatocellular carcinoma patients after curative resection. Journal of Cancer Research and Clinical Oncology 2013; 139(5): 773 doi: 10.1007/s00432-012-1343-7
|
| 28 |
Noboru Mitsuhashi, Souichi Kobayashi, Tomoko Doki, Fumio Kimura, Hiroaki Shimizu, Hiroyuki Yoshidome, Masayuki Ohtsuka, Atsushi Kato, Hideyuki Yoshitomi, Satoshi Nozawa, Katsunori Furukawa, Dan Takeuchi, Kosuke Suda, Seiki Miura, Masaru Miyazaki. Clinical significance of α‐fetoprotein: involvement in proliferation, angiogenesis, and apoptosis of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology 2008; 23(7pt2) doi: 10.1111/j.1440-1746.2008.05340.x
|
| 29 |
Bo Liu, Xiao Shang, Jin-Yu Shi, Guo-Zhen Cui, Xi Li, Nan-Ya Wang. Early Alpha-Fetoprotein Response Is Associated With Survival in Patients With HBV-Related Hepatocellular Carcinoma Receiving Lenvatinib. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.807189
|
| 30 |
A. A. Terentiev, N. T. Moldogazieva. Alpha-fetoprotein: a renaissance. Tumor Biology 2013; 34(4): 2075 doi: 10.1007/s13277-013-0904-y
|
| 31 |
Kailiang Zhao, Xiaoquan Zhou, Yuchun Xiao, Yanni Wang, Lu Wen. Research Progress in Alpha-fetoprotein-induced Immunosuppression of Liver Cancer. Mini-Reviews in Medicinal Chemistry 2022; 22(17): 2237 doi: 10.2174/1389557522666220218124816
|
| 32 |
Yifei Zheng, Mingyue Zhu, Mengsen Li. Effects of alpha-fetoprotein on the occurrence and progression of hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology 2020; 146(10): 2439 doi: 10.1007/s00432-020-03331-6
|
| 33 |
Yu-Liang Huang, Jun-Rong Wu, Min Fang, Hui-Liu Zhao, Zhi-Min Liu, Jian Ye, Ling-Sha Huang, Bo Zhu. The role of ERCC1 and AFP gene polymorphism in hepatocellular carcinoma. Medicine 2019; 98(14): e15090 doi: 10.1097/MD.0000000000015090
|
| 34 |
Wei Li, Kun Liu, Yi Chen, Mingyue Zhu, Mengsen Li. Role of Alpha-Fetoprotein in Hepatocellular Carcinoma Drug Resistance. Current Medicinal Chemistry 2021; 28(6): 1126 doi: 10.2174/0929867327999200729151247
|
| 35 |
Chao Zhang, Jiangtao Zhang, Jing Wang, Ying Yan, Chuanbao Zhang. Alpha‐fetoprotein accelerates the progression of hepatocellular carcinoma by promoting Bcl‐2 gene expression through an RA‐RAR signalling pathway. Journal of Cellular and Molecular Medicine 2020; 24(23): 13804 doi: 10.1111/jcmm.15962
|
| 36 |
Swathy S. Samban, Aparna Hari, Bhagyalakshmi Nair, Ayana. R. Kumar, Benjamin S. Meyer, Arun Valsan, Vinod Vijayakurup, Lekshmi R. Nath. An Insight Into the Role of Alpha-Fetoprotein (AFP) in the Development and Progression of Hepatocellular Carcinoma. Molecular Biotechnology 2023; doi: 10.1007/s12033-023-00890-0
|
| 37 |
Brian I. Carr, Ziqiu Wang, Meifung Wang, Gang Wei. Differential Effects of Vitamin K1 on AFP and DCP Levels in Patients with Unresectable HCC and in HCC Cell Lines. Digestive Diseases and Sciences 2011; 56(6): 1876 doi: 10.1007/s10620-010-1521-x
|